- Citations, last 5 years
- 39
- Works, last 5 years
- 5
- h-index
- 37
- Scientists listed
- 0
- Grants since 2016
- 50
Grants received
2024–2025 · contract · N43
Alternative Treatment for Syphilis
Thomas E. Smithgall · Fox Chase Chemical Diversity Center · funded by National Institutes of Health
2022–2024 · research · R41
Development of Host- Oriented Therapeutics Targeting Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),
Ronald N Harty · Fox Chase Chemical Diversity Center · funded by National Institutes of Health
2022–2025 · research · R41
Development of Host- Oriented Therapeutics Targeting Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),
Ronald N Harty · Fox Chase Chemical Diversity Center · funded by National Institutes of Health
2022–2024 · research · R41
Development of FosA Inhibitors to Potentiate Fosfomycin Activity in Gram-Negative Pathogens
Jay Edward Wrobel · Fox Chase Chemical Diversity Center · funded by National Institutes of Health
2022–2024 · research · R41
Development of FosA Inhibitors to Potentiate Fosfomycin Activity in Gram-Negative Pathogens
Jay Edward Wrobel · Fox Chase Chemical Diversity Center · funded by National Institutes of Health
2021–2026 · cooperative agreement · U01
Therapeutics targeting TDP-43 to treat Alzheimer's disease and related disorders
Allen Bernard Reitz · Fox Chase Chemical Diversity Center · funded by National Institutes of Health
2021–2026 · cooperative agreement · U01
Therapeutics targeting TDP-43 to treat Alzheimer's disease and related disorders
Allen Bernard Reitz · Fox Chase Chemical Diversity Center · funded by National Institutes of Health
2021–2026 · cooperative agreement · U01
Therapeutics targeting TDP-43 to treat Alzheimer's disease and related disorders
Allen Bernard Reitz · Fox Chase Chemical Diversity Center · funded by National Institutes of Health
2021–2026 · cooperative agreement · U01
Therapeutics targeting TDP-43 to treat Alzheimer's disease and related disorders
Allen Bernard Reitz · Fox Chase Chemical Diversity Center · funded by National Institutes of Health
2021–2024 · research · R41
Development of a Peptide-Drug Conjugate for Topically Treating the Viral Skin Disease Molluscum Contagiosum
Robert Paul Ricciardi · Fox Chase Chemical Diversity Center · funded by National Institutes of Health
2021–2023 · research · R41
Development of a Peptide-Drug Conjugate for Topically Treating the Viral Skin Disease Molluscum Contagiosum
Robert Paul Ricciardi · Fox Chase Chemical Diversity Center · funded by National Institutes of Health
2021–2026 · cooperative agreement · U01
Therapeutics targeting TDP-43 to treat Alzheimer's disease and related disorders
Allen Bernard Reitz · Fox Chase Chemical Diversity Center · funded by National Institutes of Health
2021–2027 · research · R42
Development of a Peptide-Drug Conjugate for Topically Treating the Viral Skin Disease Molluscum Contagiosum
Robert Paul Ricciardi · Fox Chase Chemical Diversity Center · funded by National Institutes of Health
2021–2026 · cooperative agreement · U01
Therapeutics targeting TDP-43 to treat Alzheimer's disease and related disorders
Allen Bernard Reitz · Fox Chase Chemical Diversity Center · funded by National Institutes of Health
2021–2027 · research · R42
Development of a Peptide-Drug Conjugate for Topically Treating the Viral Skin Disease Molluscum Contagiosum
Robert Paul Ricciardi · Fox Chase Chemical Diversity Center · funded by National Institutes of Health
2020–2023 · research · R41
Optimizing a Stapled-Peptide That Specifically Targets HSV-1 to Treat Herpes Ocular Keratitis
Robert Paul Ricciardi · Fox Chase Chemical Diversity Center · funded by National Institutes of Health
2020–2022 · research · R41
PROTACS Against Nef as a Functional Cure for HIV Infection
Thomas E. Smithgall · Fox Chase Chemical Diversity Center · funded by National Institutes of Health
2020–2023 · research · R43
Trypanocidal Agents that Kill Multiple Stages of the Trypanosoma cruzi Life Cycle
Mark E Mcdonnell · Fox Chase Chemical Diversity Center · funded by National Institutes of Health
2020–2022 · research · R43
Trypanocidal Agents that Kill Multiple Stages of the Trypanosoma cruzi Life Cycle
Mark E Mcdonnell · Fox Chase Chemical Diversity Center · funded by National Institutes of Health
2020–2021 · research · R41
Soft LXR Agonists for Idiopathic Pulmonary Fibrosis
Ross S Summer · Fox Chase Chemical Diversity Center · funded by National Institutes of Health
2020–2026 · research · R42
Optimizing a Stapled-Peptide That Specifically Targets HSV-1 to Treat Herpes Ocular Keratitis
Allen Bernard Reitz · Fox Chase Chemical Diversity Center · funded by National Institutes of Health
2020–2026 · research · R44
Trypanocidal Agents that Kill Multiple Stages of the Trypanosoma cruzi Life Cycle
Mark E Mcdonnell · Fox Chase Chemical Diversity Center · funded by National Institutes of Health
2020–2025 · research · R42
Optimizing a Stapled-Peptide That Specifically Targets HSV-1 to Treat Herpes Ocular Keratitis
Allen Bernard Reitz · Fox Chase Chemical Diversity Center · funded by National Institutes of Health
2020–2023 · research · R41
PROTACS Against Nef as a Functional Cure for HIV Infection
Thomas E. Smithgall · Fox Chase Chemical Diversity Center · funded by National Institutes of Health
2020–2025 · research · R42
Optimizing a Stapled-Peptide That Specifically Targets HSV-1 to Treat Herpes Ocular Keratitis
Allen Bernard Reitz · Fox Chase Chemical Diversity Center · funded by National Institutes of Health
2020–2026 · research · R44
Trypanocidal Agents that Kill Multiple Stages of the Trypanosoma cruzi Life Cycle
Mark E Mcdonnell · Fox Chase Chemical Diversity Center · funded by National Institutes of Health
2020–2027 · research · R44
Trypanocidal Agents that Kill Multiple Stages of the Trypanosoma cruzi Life Cycle
Mark E Mcdonnell · Fox Chase Chemical Diversity Center · funded by National Institutes of Health
2019–2020 · research · R41
Discovering a Small Molecule that Targets the KSHV Processivity Factor for Treating Oral and Systemic Kaposi Sarcoma
Robert Paul Ricciardi · Fox Chase Chemical Diversity Center · funded by National Institutes of Health
2018–2021 · research · R41
Trigriluzole for the Treatment of Cocaine Addiction
Scott M. Rawls · Fox Chase Chemical Diversity Center · funded by National Institutes of Health
2018–2020 · research · R43
Soft LXR Agonists for the Treatment of Idiopathic Pulmonary Fibrosis
Jay Edward Wrobel · Fox Chase Chemical Diversity Center · funded by National Institutes of Health
2018–2020 · research · R41
Development of Small Molecule Therapeutics Targeting Hemorrhagic Fever Viruses
Ronald N Harty · Fox Chase Chemical Diversity Center · funded by National Institutes of Health
2018–2025 · research · R42
Development of Small Molecule Therapeutics Targeting Hemorrhagic Fever Viruses
Ronald N Harty · Fox Chase Chemical Diversity Center · funded by National Institutes of Health
2018–2024 · research · R42
Development of Small Molecule Therapeutics Targeting Hemorrhagic Fever Viruses
Ronald N Harty · Fox Chase Chemical Diversity Center · funded by National Institutes of Health
2018–2024 · research · R42
Development of Small Molecule Therapeutics Targeting Hemorrhagic Fever Viruses
Ronald N Harty · Fox Chase Chemical Diversity Center · funded by National Institutes of Health
2018–2021 · research · R41
Development of Small Molecule Therapeutics Targeting Hemorrhagic Fever Viruses
Ronald N Harty · Fox Chase Chemical Diversity Center · funded by National Institutes of Health
2017–2019 · research · R43
INHIBITORS OF THE PHD2 ZINC FINGER TO TREAT ANEMIA
Jay Edward Wrobel · Fox Chase Chemical Diversity Center · funded by National Institutes of Health
2017–2019 · research · R41
Inhibitors of Hydrogen Sulfide Metabolism as a Novel Treatment for Heart Failure
Marilyn S Jorns · Fox Chase Chemical Diversity Center · funded by National Institutes of Health
2017–2019 · research · R41
DEVELOPMENT OF A NOVEL ANTIVIRAL TO TREAT AND PREVENT ACYCLOVIR RESISTANCE IN HUMAN OCULAR HERPES KERATITIS
Robert Paul Ricciardi · Fox Chase Chemical Diversity Center · funded by National Institutes of Health
2017–2020 · research · R44
PET Imaging Agents for the in vivo Detection of TDP-43
Allen Bernard Reitz · Fox Chase Chemical Diversity Center · funded by National Institutes of Health
2017–2019 · research · R44
PET Imaging Agents for the in vivo Detection of TDP-43
Allen Bernard Reitz · Fox Chase Chemical Diversity Center · funded by National Institutes of Health
